Accelerated radiation therapy in non-small cell lung cancer

Editorial

M Baumann. Radiother Oncol. 1999 Aug.

. 1999 Aug;52(2):97-9.

doi: 10.1016/s0167-8140(99)00111-5.

No abstract available

Comment in

Accelerated radiotherapy vs. chemoradiation in non-small cell lung cancer: quantifying the hazards.
Bentzen SM, Saunders MI, Dische S, Parmar MK. Bentzen SM, et al. Radiother Oncol. 2001 Jan;58(1):91-2. doi: 10.1016/s0167-8140(00)00311-x. Radiother Oncol. 2001. PMID: 11258343 No abstract available.

A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial.
Ball D, Bishop J, Smith J, O'Brien P, Davis S, Ryan G, Olver I, Toner G, Walker Q, Joseph D. Ball D, et al. Radiother Oncol. 1999 Aug;52(2):129-36. doi: 10.1016/s0167-8140(99)00093-6. Radiother Oncol. 1999. PMID: 10577698 Clinical Trial.
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee.
Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Palmar M. Saunders M, et al. Radiother Oncol. 1999 Aug;52(2):137-48. doi: 10.1016/s0167-8140(99)00087-0. Radiother Oncol. 1999. PMID: 10577699 Clinical Trial.